NIH-funded research NIH-funded research

Investigating genetic variants linked to substance use disorders

Official title: High-Throughput Functional Genomics of Variants in Genes Linked to Substance Use Disorders

Funded at Washington University · NIH-10895531 · Data updated 2026-11-12

This study is looking at how our genes might affect substance use disorders, and it's for anyone interested in understanding how genetics can help create better treatments for addiction.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startAugust 1, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$466,500
NIH project number5DP1DA058706-02
Project IDNIH-10895531 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a history of substance use disorders or those who are genetically predisposed to such conditions.

Less likely to help

Patients who do not have a genetic predisposition to substance use disorders may not benefit from this research.

What this research studies

This research focuses on understanding the genetic factors that contribute to substance use disorders by examining thousands of genetic variants identified through previous studies. It employs advanced techniques like Massively Parallel Reporter Assays (MPRAs) to experimentally test these variants and determine their functional significance. By uncovering how these genetic variants influence behavior and addiction, the research aims to pave the way for developing targeted therapies. Patients may benefit from insights that could lead to more effective treatments tailored to their genetic profiles.

Why it matters

Potential benefit: If successful, this research could lead to the development of personalized treatments for substance use disorders based on individual genetic profiles.

How similar studies have gone: Previous research has shown success in using high-throughput genomics to identify genetic factors in various disorders, suggesting a promising approach for this study.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Baldridge, Dustin M — Washington University
  • Study coordinator: Baldridge, Dustin M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.